PerkinElmer
PerkinElmer Prices Senior Notes Offering
The $2.3 billion offering will provide some of the money PerkinElmer needs to complete its planned acquisition of BioLegend.
PerkinElmer Reaches Deal for $1.5B Credit Facility
The agreement is for a new credit facility, which replaces one from 2019 that provided for a $1 billion unsecured revolving credit facility.
PerkinElmer Enters $500M Credit Facility
The proceeds will be used to pay, in part, PerkinElmer's $5.25B acquisition of BioLegend, announced last month.
GenomeWeb Index Gains Slightly in July as Fluidigm, PerkinElmer, Bio-Rad Post Strong Increases
The GenomeWeb Index outperformed the Dow Jones, Nasdaq, and Nasdaq Biotechnology Index last month.
GenomeWeb Index Down in May as NanoString Technologies Falls 30 Percent From April
The GenomeWeb Index underperformed the Dow Jones, the Nasdaq, and the Nasdaq Biotechnology Index last month.
Mar 4, 2021
PerkinElmer to Offer $800M in Senior Notes
Feb 2, 2021
PerkinElmer Q4 Revenues Spike 68 Percent
Jan 11, 2021
PerkinElmer Q4 Revenues Expected to Rise 66 Percent
Jan 7, 2021
PerkinElmer to Buy Oxford Immunotec for $591M
Nov 2, 2020
PerkinElmer to Buy Horizon Discovery for $383M
Oct 28, 2020
PerkinElmer Q3 Revenues Spike 36 Percent
Jul 29, 2020